Free Trial
LON:VSN

Verseon (VSN) Share Price, News & Analysis

About Verseon Stock (LON:VSN)

Key Stats

Today's Range
N/A
50-Day Range
74
74
52-Week Range
N/A
Volume
3,000 shs
Average Volume
75,334 shs
Market Capitalization
£112.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Verseon Corporation, a pharmaceutical company, designs and develops novel therapeutics for various diseases in the United States. The company is involved in developing oral anticoagulants for various cardiovascular indications with novel pharmacology; kallikrein inhibitors for the treatment of diabetic macular edema and hereditary angioedema; and novel angiogenesis inhibitors for the treatment of solid tumors. Verseon Corporation was founded in 2002 and is headquartered in Fremont, California.

Receive VSN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Verseon and its competitors with MarketBeat's FREE daily newsletter.

VSN Stock News Headlines

Dragon Age: The Veilguard Review
I was wrong. Dead wrong.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Headlines

VSN Stock Analysis - Frequently Asked Questions

Shares of VSN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Verseon investors own include Unity Biotechnology (UBX), Constellation Brands (STZ), NVIDIA (NVDA) and Netflix (NFLX).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
GBX 21 per share

Miscellaneous

Free Float
N/A
Market Cap
£112.24 million
Optionable
Not Optionable
Beta
N/A
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (LON:VSN) was last updated on 11/9/2024 by MarketBeat.com Staff
From Our Partners